Verrica Pharmaceuticals Stock Analysis

Verrica Stock Analysis Notes

About 44.0% of the company outstanding shares are owned by insiders. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Verrica Pharmaceuticals recorded a loss per share of 1.84. The entity had not issued any dividends in recent years. Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania. Verrica Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people. For more information please call Ted White at 484 453 3300 or visit https://www.verrica.com.

Verrica Pharmaceuticals Investment Alerts

Verrica Pharmaceuticals Upcoming and Recent Events

Verrica Largest EPS Surprises

View All Earnings Estimates

Verrica Pharmaceuticals Thematic Classifications

Verrica Stock Institutional Investors

Note, although Verrica Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Verrica Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 115.92 M.

Verrica Profitablity

Management Efficiency

Verrica Pharmaceuticals has return on total asset (ROA) of (0.7141) % which means that it has lost $0.7141 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (20.5989) %, meaning that it created substantial loss on money invested by shareholders. Verrica Pharmaceuticals' management efficiency ratios could be used to measure how well Verrica Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of December 1, 2024, Return On Tangible Assets is expected to decline to -0.86. In addition to that, Return On Capital Employed is expected to decline to -1.07. At present, Verrica Pharmaceuticals' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 3.9 M, whereas Total Assets are forecasted to decline to about 62 M.

Technical Drivers

As of the 1st of December, Verrica Pharmaceuticals has the Risk Adjusted Performance of (0.02), variance of 91.31, and Coefficient Of Variation of (2,374). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Verrica Pharmaceuticals, as well as the relationship between them.

Verrica Pharmaceuticals Price Movement Analysis

Verrica Pharmaceuticals Insider Trading Activities

Verrica Pharmaceuticals Outstanding Bonds

Verrica Pharmaceuticals Predictive Daily Indicators

Verrica Pharmaceuticals Forecast Models

Verrica Pharmaceuticals' time-series forecasting models are one of many Verrica Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Verrica Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Verrica Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Verrica shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Verrica Pharmaceuticals. By using and applying Verrica Stock analysis, traders can create a robust methodology for identifying Verrica entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Verrica analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Verrica analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Verrica Pharmaceuticals stock analysis indicators help investors evaluate how Verrica Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Verrica Pharmaceuticals shares will generate the highest return on investment. By understating and applying Verrica Pharmaceuticals stock analysis, traders can identify Verrica Pharmaceuticals position entry and exit signals to maximize returns.

When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.